Alpine Immune Sciences to Report Third Quarter 2022 Financial Results

Rhea-AI Summary

Alpine Immune Sciences, Inc. (NASDAQ: ALPN) announced it will release its third quarter 2022 financial results on November 14, 2022, after market close. A conference call and live webcast will take place at 4:30 p.m. ET. The webcast will be accessible via their investor relations website, with a replay available for 90 days post-event. Alpine is focused on developing innovative immunotherapy treatments for autoimmune and inflammatory diseases, backed by strong research collaboration and a diverse pipeline of candidates.

Positive

• The company is committed to innovative immunotherapy, indicating potential for growth.
• Strategic collaborations with leading biopharmaceutical companies enhance its development capabilities.
• Diverse pipeline of clinical and preclinical candidates suggests strong future prospects.

Negative

• None.

SEATTLE--(BUSINESS WIRE)-- Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases, today announced the company will release third quarter 2022 financial results on Monday, November 14, 2022, after the close of market. The Company will host a corresponding conference call and live webcast at 4:30 p.m. ET/1:30 p.m. PT on the same day.

Conference Call and Webcast Information

The link to the webcast will be available in the investor relations section of the Company’s website at https://ir.alpineimmunesciences.com/events and a replay will be available on the Company's website for 90 days following the live event.

About Alpine Immune Sciences

Alpine Immune Sciences is committed to leading a new wave of immune therapeutics. With world-class research and development capabilities, a highly productive scientific platform, and a proven management team, Alpine is seeking to create first- or best-in-class multifunctional immunotherapies via unique protein engineering technologies to improve patients’ lives. Alpine has entered into strategic collaborations with leading global biopharmaceutical companies and has a diverse pipeline of clinical and preclinical candidates in development. For more information, visit www.alpineimmunesciences.com. Follow @AlpineImmuneSci on Twitter and LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221107006061/en/

Temre Johnson (Investors)

Alpine Immune Sciences, Inc.

ir@alpineimmunesciences.com

Kelli Perkins (Media)

Red House

kelli@redhousecomms.com

Source: Alpine Immune Sciences, Inc.

FAQ

When will Alpine Immune Sciences release its Q3 2022 financial results?

Alpine Immune Sciences will release its Q3 2022 financial results on November 14, 2022, after market close.

What time is the conference call for Alpine Immune Sciences' Q3 results?

The conference call for Alpine Immune Sciences' Q3 results will be held at 4:30 p.m. ET on November 14, 2022.

Where can I access the webcast for Alpine Immune Sciences' Q3 financial results?

The webcast for Alpine Immune Sciences' Q3 financial results can be accessed on their investor relations website.

What is the focus of Alpine Immune Sciences?

Alpine Immune Sciences focuses on developing innovative treatments for autoimmune and inflammatory diseases through immunotherapy.